| Q52655176 | A role for the clock period circadian regulator 2 gene in regulating the clock gene network in human oral squamous cell carcinoma cells. |
| Q34456099 | Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer |
| Q34584583 | Aberrant expression of clock gene period1 and its correlations with the growth, proliferation and metastasis of buccal squamous cell carcinoma |
| Q41964762 | Abnormal expression of PER1 circadian-clock gene in oral squamous cell carcinoma |
| Q45416449 | Altered expression of SIRT gene family in head and neck squamous cell carcinoma. |
| Q52632582 | Altered expression patterns of clock gene mRNAs and clock proteins in human skin tumors. |
| Q36133442 | Association of sleep duration and breast cancer OncotypeDX recurrence score |
| Q36121128 | Carcinogenic effects of circadian disruption: an epigenetic viewpoint. |
| Q37645333 | Casein kinase 1 epsilon expression predicts poorer prognosis in low T-stage oral cancer patients |
| Q64243089 | Chronodentistry: the role & potential of molecular clocks in oral medicine |
| Q92445608 | Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma |
| Q28081588 | Circadian System and Melatonin Hormone: Risk Factors for Complications during Pregnancy |
| Q50045797 | Circadian clock and oral cancer |
| Q38100902 | Circadian clocks and tumor biology: what is to learn from human skin biopsies? |
| Q43727958 | Circadian gene expression and clinicopathologic correlates in pancreatic cancer. |
| Q36261585 | Circadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer |
| Q34127839 | Circadian gene variants in cancer. |
| Q36945752 | Circadian rhythm connections to oxidative stress: implications for human health |
| Q38372792 | Circadian systems biology in Metazoa |
| Q40395833 | Circadian variations of clock gene Per2 and cell cycle genes in different stages of carcinogenesis in golden hamster buccal mucosa |
| Q37602726 | Clock genes: their role in colorectal cancer |
| Q64237904 | Current Status of Research on the Period Family of Clock Genes in the Occurrence and Development of Cancer |
| Q46942289 | DEC2 Blocks the Effect of the ARNTL2/NPAS2 Dimer on the Expression of PER3 and DBP. |
| Q92599596 | DNA methylation signature is prognostic of choroid plexus tumor aggressiveness |
| Q35174438 | Daily rhythms are retained both in spontaneously developed sarcomas and in xenografts grown in immunocompromised SCID mice. |
| Q53084256 | Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia. |
| Q35141105 | Deregulated expression of circadian clock genes in gastric cancer |
| Q27011441 | Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies |
| Q36087886 | Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes |
| Q36634647 | Genetic polymorphisms in circadian negative feedback regulation genes predict overall survival and response to chemotherapy in gastric cancer patients |
| Q55644945 | Histone deacetylase inhibitors induce the expression of tumor suppressor genes Per1 and Per2 in human gastric cancer cells. |
| Q43207027 | Impaired light detection of the circadian clock in a zebrafish melanoma model. |
| Q39361718 | Krüppel-like factor 5: a novel biomarker for lymph node metastasis and recurrence in supraglottic squamous cell laryngeal carcinoma |
| Q38826610 | Low cytoplasmic casein kinase 1 epsilon expression predicts poor prognosis in patients with hepatocellular carcinoma |
| Q34555750 | MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. |
| Q91876369 | Overexpression of the clock gene Per2 suppresses oral squamous cell carcinoma progression by activating autophagy via the PI3K/AKT/mTOR pathway |
| Q44170967 | PER1 and CLOCK: potential circulating biomarkers for head and neck squamous cell carcinoma |
| Q92644810 | Period 3, a tumor suppressor in non-small cell lung cancer, is silenced by hypermethylation |
| Q98735980 | Period Family of Clock Genes as Novel Predictors of Survival in Human Cancer: A Systematic Review and Meta-Analysis |
| Q47367521 | Prognostic significance of downregulated BMAL1 and upregulated Ki-67 proteins in nasopharyngeal carcinoma |
| Q41902787 | Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification |
| Q35751343 | Retracted: Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric Cancer |
| Q38204315 | Running for time: circadian rhythms and melanoma. |
| Q30405372 | Sleep Disturbance and Altered Expression of Circadian Clock Genes in Patients With Sudden Sensorineural Hearing Loss |
| Q28391366 | Sleep duration and breast cancer phenotype |
| Q64108778 | Systems Biology Approaches and Precision Oral Health: A Circadian Clock Perspective |
| Q28390451 | The circadian clock in cancer development and therapy |
| Q38142908 | The circadian clock in oral health and diseases |
| Q37190376 | The clock gene PER1 suppresses expression of tumor-related genes in human oral squamous cell carcinoma |
| Q28388257 | The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis |
| Q64974084 | The role of circadian clock genes in tumors. |
| Q48290677 | The search for preoperative biomarkers for thyroid carcinoma: application of the thyroid circadian clock properties |
| Q64097309 | Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies |
| Q38184659 | Watching the clock: endoplasmic reticulum-mediated control of circadian rhythms in cancer |